Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2022-09-06 Annual Report
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Annual General Meeting
Annual Report Classification · 100% confidence The document is titled '34th Annual Report 2021-22 and Notice of the 34th Annual General Meeting of Wanbury Limited' and contains detailed sections including the Notice of AGM, Director's Report, Management Discussion and Analysis, Corporate Governance Report, Auditors' Report, Standalone and Consolidated Financial Statements, and other related information. It includes comprehensive financial data and corporate governance details for the fiscal year ending 31 March 2022. The document is lengthy (15,000 characters) and contains the full annual report content, not just an announcement or a notice of report publication. Therefore, it fits the definition of an Annual Report (10-K).
2022-09-06 English
This is to inform you that the 34th Annual General Meeting of the Members of the Company will be held on Wednesday, 28th September, 2022 at 11:30 A.M. through Video Conference (VC) or Other ....
Regulatory Filings
2022-09-06 English
The 34th Annual General Meeting ('AGM') of Wanbury Limited ('the Company') will be held on Wednesday, 28th September, 2022, at 11.30 AM through Video Conferencing / Other Audio Visual Means. ....
Regulatory Filings
2022-09-06 English
The 34th Annual General Meeting ('AGM') of Wanbury Limited ('the Company') will be held on Wednesday, 28th September, 2022, at 11.30 AM through Video Conferencing / Other Audio Visual Means. ....
Regulatory Filings
2022-09-06 English
Pursuant to Regulation 30 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies issued for attention ....
Regulatory Filings
2022-08-30 English
Newspaper Advertisements
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the 34th Annual General Meeting (AGM) of Wanbury Limited. It mentions the date and mode of the AGM (through Video Conference/Other Audio Visual Means) and includes newspaper clippings published for shareholders' information. The content is about informing the exchanges and shareholders about the AGM details, not the AGM materials or presentations themselves. The document is relatively short and serves as an announcement or notification about the AGM event rather than the AGM report or presentation. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related official communications about the AGM event.
2022-08-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.